The safety of blood and the quantification of transfusion risks have been dominant themes that have stimulated the development of alternative approaches in this rapidly developing area. In clinical medicine conventional blood and its components are used in supportive therapies dependent on the choice of apparent uncritical trigger factors.

This book will be of timely value to students, professionals and all others interested or involved in the field of transfusion medicine, whether clinical or related.

The clinical setting - how to optimize supportive haemotherapy
chemical and biological alternatives
alternative approaches in clinical practice
the balance of risks
benefits and costs.